http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007010525-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4662463827d354505f66e06e033c08d4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2006-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6050cae899ad1e130be20316a711ef43 |
| publicationDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2007010525-A1 |
| titleOfInvention | Method and compositions for modulating neuropeptide hormone secretion |
| abstract | Methods for increasing the release of oxytocin or vasopressin or both from the posterior pituitary of a mammal in need thereof, comprising administering to the mammal an effective amount of a cyclic guanosine 3′,5′-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitor to the mammal. The method is particularly useful to treat pregnant female or postnatal mammal wherein labor, fetal expulsion, or milk let-down or production needs to be induced, enhanced or augmented. Also provided are pharmaceutical compositions suitable for the inventive method. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799554-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792326-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016175385-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9655435-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013323288-A1 |
| priorityDate | 2005-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 484.